Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Pacer--OPPOSITION OF PLAINTIFFS HTC CORPORATION AND HTC AMERICA, INC. TO DEF

Of the three patents-in-suit that were the subject of the prior Texas case, TPL has removed one of them from this case by choosing not to assert it (U.S. Patent No. 5,784,584). A second patent from the prior case (U.S. Patent No. 6,598,148) expires in seven months (many years before the other patents-in-suit), while the third patent (U.S. Patent No. 5,809,336) is currently in reexamination before the Patent Office where all claims presently stand rejected.

http://agoracom.com/ir/patriot/forum...





Be well





Share
New Message
Please login to post a reply